Fact CheckerSign in

NCT07191366Not yet recruiting

Antenatal Breastmilk Expression in Pregnant Women at High Risk of Preterm Birth

EXPRESSMOM2 in Pregnant Women at High Risk of Preterm Birth. Aspects of Antenatal Breastmilk Expression and Safety From Gestational Week 28-34 and Potential Nutritional Benefits for the Newborn Infant.

Source: ClinicalTrials.gov · Last updated 24 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

In this randomized controlled study, the investigators aim to examine if antenatal breastmilk expression (aBME) from week 28 in high-risk pregnancies is a safe and effective method to ensure early access to mother's own milk. In addition, this study will analyze and compare colostrum from pregnancy with colostrum after birth, investigates women's confidence in breastfeeding and breastfeeding establishment as well as measures oxytocin levels during aBME and active labour with no aBME.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
250 (estimated)
First submitted
1 Sept 2025
Start date
Sept 2026
Primary completion date
Jan 2029
Lead sponsor
Odense University Hospital
NCT number
NCT07191366

What you commit to

  • Study type: Interventional
  • Planned participants: 250
  • From Sept 2026 to the primary completion date, Jan 2029
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Women taking medications contraindicating breastfeeding
  • Women with prior breast reductive surgery or mastectomy

Age

  • Below 18 years of age

Other

  • HELLP or severe preeclampsia indicating expected induction of labour/caesarean section within a few days (According to national guidelines)
  • Chorioamnionitis indicating induction of labour/caesarean section within a few days
  • Women with a vaginal cerclage and PPROM
  • Contractions to a certain extend expecting delivery within a few days
  • Included in other trials, where breastfeeding is among outcomes

Who the study is looking for

  • Pregnant women with a GA between 28 weeks and 0 days and 34 weeks and 0 days who are either diagnosed with preeclampsia or PPROM or have previously given birth before 34 weeks of gestation
  • Resident in the Region of Southern Denmark
  • Women speaking and understanding Danish or English
  • Planning to breastfeed their infants

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.